UPDATE 1-Valeant psoriasis drug's suicide risk hard to assess -FDA Staff

July 15 (Reuters) - Valeant Pharmaceuticals International

Inc's experimental drug to treat the skin disorder

psoriasis carries a potential risk of suicide that is

challenging to assess due to limited...

Read more